Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2447973660;73661;73662 chr2:178572697;178572696;178572695chr2:179437424;179437423;179437422
N2AB2283868737;68738;68739 chr2:178572697;178572696;178572695chr2:179437424;179437423;179437422
N2A2191165956;65957;65958 chr2:178572697;178572696;178572695chr2:179437424;179437423;179437422
N2B1541446465;46466;46467 chr2:178572697;178572696;178572695chr2:179437424;179437423;179437422
Novex-11553946840;46841;46842 chr2:178572697;178572696;178572695chr2:179437424;179437423;179437422
Novex-21560647041;47042;47043 chr2:178572697;178572696;178572695chr2:179437424;179437423;179437422
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: AGC
  • RefSeq wild type template codon: TCG
  • Domain: Ig-132
  • Domain position: 49
  • Structural Position: 131
  • Q(SASA): 0.7227
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/G rs1303034746 None 0.815 N 0.249 0.098 0.0716867268079 gnomAD-3.1.2 6.58E-06 None None None None N None 2.41E-05 0 0 0 0 None 0 0 0 0 0
S/G rs1303034746 None 0.815 N 0.249 0.098 0.0716867268079 gnomAD-4.0.0 2.56331E-06 None None None None N None 3.38513E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.0789 likely_benign 0.0824 benign -0.56 Destabilizing 0.543 D 0.333 neutral None None None None N
S/C 0.1864 likely_benign 0.1899 benign -0.326 Destabilizing 0.994 D 0.351 neutral N 0.478697894 None None N
S/D 0.3816 ambiguous 0.3914 ambiguous 0.353 Stabilizing 0.009 N 0.23 neutral None None None None N
S/E 0.5296 ambiguous 0.5317 ambiguous 0.256 Stabilizing 0.59 D 0.257 neutral None None None None N
S/F 0.3188 likely_benign 0.3581 ambiguous -1.178 Destabilizing 0.91 D 0.392 neutral None None None None N
S/G 0.0893 likely_benign 0.0924 benign -0.652 Destabilizing 0.815 D 0.249 neutral N 0.419455453 None None N
S/H 0.4743 ambiguous 0.4931 ambiguous -1.218 Destabilizing 0.996 D 0.31 neutral None None None None N
S/I 0.2533 likely_benign 0.2704 benign -0.443 Destabilizing 0.015 N 0.293 neutral N 0.46034015 None None N
S/K 0.7975 likely_pathogenic 0.8137 pathogenic -0.394 Destabilizing 0.854 D 0.288 neutral None None None None N
S/L 0.1295 likely_benign 0.1413 benign -0.443 Destabilizing 0.331 N 0.351 neutral None None None None N
S/M 0.2441 likely_benign 0.2541 benign -0.105 Destabilizing 0.974 D 0.31 neutral None None None None N
S/N 0.1456 likely_benign 0.154 benign -0.088 Destabilizing 0.684 D 0.34 neutral N 0.482971001 None None N
S/P 0.116 likely_benign 0.1249 benign -0.456 Destabilizing 0.004 N 0.259 neutral None None None None N
S/Q 0.5674 likely_pathogenic 0.5838 pathogenic -0.371 Destabilizing 0.953 D 0.289 neutral None None None None N
S/R 0.7733 likely_pathogenic 0.7912 pathogenic -0.258 Destabilizing 0.939 D 0.314 neutral N 0.508618807 None None N
S/T 0.0916 likely_benign 0.0953 benign -0.261 Destabilizing 0.684 D 0.295 neutral N 0.513640624 None None N
S/V 0.2198 likely_benign 0.2377 benign -0.456 Destabilizing 0.331 N 0.355 neutral None None None None N
S/W 0.5677 likely_pathogenic 0.5818 pathogenic -1.127 Destabilizing 0.996 D 0.517 neutral None None None None N
S/Y 0.3298 likely_benign 0.3681 ambiguous -0.864 Destabilizing 0.953 D 0.389 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.